HK Stock Market Move | DAHON TECH (02543) rose over 14% in the afternoon, up over 27% from its IPO price. The company is ranked first in the folding bicycle industry in mainland China.
After its IPO, China General Technology (02543) once fell below its issue price. Today, its intraday high reached 63 Hong Kong dollars, rising over 27% from the IPO price of 49.5 Hong Kong dollars. As of the time of writing, it has risen by 13.36% to 62.35 Hong Kong dollars, with a trading volume of 143 million Hong Kong dollars.
After listing, DAHON TECH (02543) experienced a period of breaking, with the price reaching a high of 63 Hong Kong dollars today, up over 27% from the offer price of 49.5 Hong Kong dollars. As of the time of writing, it has risen by 13.36%, reaching 62.35 Hong Kong dollars, with a turnover of 143 million Hong Kong dollars.
Public information shows that DAHON TECH is the largest folding bike company in mainland China, ranking first in both retail sales volume and retail sales value of folding bikes in 2024. According to information from Lighthouse Consulting, the company ranks first in the folding bike industry in mainland China in terms of retail sales volume in 2024, with a market share of 26.3%, and also ranks first in terms of retail sales value, with a market share of 36.5%. As of April 30, 2025, the company offers more than 70 bike models.
According to information from Lighthouse Consulting, the company has the most patents in the folding bike industry in China, with 113 valid patents in mainland China as of April 30, 2025. On the same day, the company also has 22 valid patents in the United States, Europe, and Japan. Guoyuan International previously commented that the company is a leader in the sub-sector of the bicycle industry and is in a growth stage. The total market value of this IPO is 1.567 billion Hong Kong dollars, with an offer price corresponding to a static PE ratio of about 27.4 times, higher than the industry average valuation of 22 times.
Related Articles

TYK MEDICINES-B (02410): Zhang Senquan resigns as independent non-executive director.

At the end of August, the comprehensive net asset value per share of C FIN INT INV (00721) was approximately 0.02 Hong Kong dollars.

TENFU(06868) spent 12,100 Hong Kong dollars to repurchase 4,000 shares on September 15th.
TYK MEDICINES-B (02410): Zhang Senquan resigns as independent non-executive director.

At the end of August, the comprehensive net asset value per share of C FIN INT INV (00721) was approximately 0.02 Hong Kong dollars.

TENFU(06868) spent 12,100 Hong Kong dollars to repurchase 4,000 shares on September 15th.

RECOMMEND

Hong Kong Stock Concept Tracker|Oracle (ORCL.US) RPO Surge Ignites AI Computing Power Chain—Domestic Opportunities in Focus
11/09/2025

Southbound Capital Flows Shift: Profit-Taking on High-Flying Stocks and Accumulating Alibaba and Tence
11/09/2025

Anti-Involution Policies Deliver Results as August Price Indicators Improve
11/09/2025